Yogurt beverages as a vehicle to deliver high dose probiotics
酸奶饮料作为提供高剂量益生菌的载体
基本信息
- 批准号:7937876
- 负责人:
- 金额:$ 21.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAgeAnorexiaAntibioticsAreaAsthmaAttentionBacteriaBeveragesBifidobacteriumBiological AvailabilityBreast FeedingChildChild health careClinical TrialsColony-forming unitsConsumptionCounselingDairy ProductsDataDiarrheaDiseaseDoseDrug FormulationsEtiologyFailureFeasibility StudiesFecesFoodFutureGastrointestinal tract structureGoalsHealthHealth BenefitHypersensitivityImageIncidenceInfantInterventionIntestinesInvestigationLifeLiquid substanceMissionModalityNational Center for Complementary and Alternative MedicineNecrotizing EnterocolitisNutrientNutritionalOralOutcomeOutcome StudyParentsParticipantPatientsPenicillinsPharmacologic SubstancePharmacologyPlacebo ControlPlacebosPlayPopulationPowder dose formPreparationPreventionPrimary Care PhysicianProbioticsPublic HealthRecoveryRegimenRehydrationsReportingResearchResearch DesignRiskRoleScheduleSourceStrategic PlanningSurrogate MarkersUnited StatesYogurtbasecapsuledesigndosagedrinkingeffectiveness clinical trialfunctional foodimprovedmicroorganismnutritionpillpreventpublic health relevanceresponsetransmission process
项目摘要
DESCRIPTION (provided by applicant): Probiotics are live microorganisms that, when administered in sufficient amounts, may improve health. Often, probiotics are ingested as supplements in powder, pill or liquid forms, designed specifically for medicinal benefit. Yogurt can be an effective delivery vehicle for probiotics, but generally yogurts available in the United States are not formulated with attention to optimal probiotic strains or dose. Yogurt is also an attractive delivery agent because of its popularity with parents and children, likely improving compliance. We propose to evaluate yogurt formulated with a probiotic strain at a dose that results in recovery in stools. The long-term goal of this project is to demonstrate that a probiotic-containing yogurt beverage can be used successfully as a vehicle for delivering health-enhancing probiotics to children. The specific goals of this study are to determine if a yogurt drink containing Bifidobacterium lactis (Bb-12) at a minimum 1010 colony forming units (CFU)/per serving can prevent antibiotic-associated diarrhea (AAD). We have three specific aims to accomplish these goals. Aim #1: To determine if consumption of a yogurt drink containing a high dose of probiotics decreases the incidence of antibiotic-associated diarrhea in children ages 1-3 taking a penicillin-class antibiotic compared to a matching placebo drink. Aim #2: To evaluate the feasibility of children consuming a drinkable yogurt on a regular daily basis when the children are ill. Aim #3: To determine if the supplemental Bb-12 probiotics survive the gastrointestinal tract and can be recovered from the stools of participants consuming the Bb-12 yogurt drink. This proposal is in direct response to a PA and our Aims are in consort with NCCAM's mission. NCCAM has identified areas of research needing further investigation, stating, "Use of adequately defined products and optimal dosage schedules in studies decreases the risk of failures that might discourage further research into otherwise promising modalities." Therefore, NCCAM recommends studies designed to: 1) determine active ingredients, pharmacology, bioavailability and optimal dosing; 2) identify surrogate markers; and, 3) assess study feasibility. The outcomes of these studies will form the basis for designing larger trials with an enhanced ability to detect a meaningful positive effect of the therapy under study. A readily available yogurt with high dose probiotics has the potential to positively impact the health of children around the world, as yogurt will likely be more appealing to both children and their parents for long term consumption than pharmaceutical-like probiotic preparations.
Public Health Relevance: Probiotics are live microorganisms that, when administered in sufficient amounts, may improve health. Generally probiotics are ingested as supplements in powder, pill or liquid forms, designed specifically for medicinal benefit. Probiotics may be included as ingredients in fermented dairy products. A probiotic-containing yogurt beverage can potentially be used successfully as a vehicle for delivering health-enhancing probiotics to children, resulting in a functional food; that is a food providing health benefits beyond its nutritional value. Our primary aim is to see if a high dose probiotic drink can prevent antibiotic-associated diarrhea in children ages 1-3 taking a penicillin-class antibiotic. Additionally, this study will allow us to assess the feasibility of this approach to delivering probiotics in a food product and, if successful, in the future enhance other aspects of health.
描述(由申请人提供):益生菌是活的微生物,当给予足够的量时,可以改善健康。通常,益生菌是作为粉末,药丸或液体形式的补充剂摄入的,专为药用而设计。酸奶可以是益生菌的有效载体,但通常在美国可用的酸奶没有注意到最佳益生菌菌株或剂量。酸奶也是一种有吸引力的传递剂,因为它在父母和孩子中很受欢迎,可能会提高依从性。我们建议评估用益生菌菌株配制的酸奶,其剂量导致粪便中的恢复。该项目的长期目标是证明含有益生菌的酸奶饮料可以成功地用作向儿童提供增强健康的益生菌的载体。本研究的具体目标是确定是否含有乳酸双歧杆菌(Bb-12)的酸奶饮料在至少1010菌落形成单位(CFU)/每份可以预防腹泻相关性腹泻(AAD)。我们有三个具体目标来实现这些目标。目标一:为了确定与匹配的安慰剂饮料相比,消费含有高剂量益生菌的酸奶饮料是否降低服用青霉素类抗生素的1-3岁儿童的腹泻相关性腹泻的发病率。目标#2:评估儿童生病时每天定期饮用酸奶的可行性。目标3:确定补充的Bb-12益生菌是否能在胃肠道中存活,并能从食用Bb-12酸奶饮料的参与者的粪便中回收。这一建议是对PA的直接回应,我们的目标与NCCAM的使命一致。NCCAM已经确定了需要进一步调查的研究领域,指出:“在研究中使用充分定义的产品和最佳剂量方案降低了失败的风险,这可能会阻碍进一步研究其他有前途的模式。因此,NCCAM建议进行以下研究:1)确定活性成分,药理学,生物利用度和最佳剂量; 2)确定替代标志物; 3)评估研究可行性。这些研究的结果将为设计更大规模的试验奠定基础,这些试验具有更强的能力来检测所研究的治疗的有意义的积极作用。一种容易获得的含有高剂量益生菌的酸奶有可能对世界各地儿童的健康产生积极影响,因为酸奶可能比药物类益生菌制剂更能吸引儿童及其父母长期食用。
公共卫生相关性:益生菌是活的微生物,当给予足够的量时,可以改善健康。一般来说,益生菌是以粉末、药丸或液体形式作为补充剂摄入的,专门为药用而设计。益生菌可以作为发酵乳制品中的成分。含有益生菌的酸奶饮料可以成功地用作向儿童递送增强健康的益生菌的媒介物,从而产生功能性食品;这是一种提供超出其营养价值的健康益处的食品。我们的主要目的是看看高剂量益生菌饮料是否可以预防1-3岁服用青霉素类抗生素的儿童的腹泻。此外,这项研究将使我们能够评估这种方法在食品中提供益生菌的可行性,如果成功的话,将来可以提高健康的其他方面。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL J MERENSTEIN其他文献
DANIEL J MERENSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL J MERENSTEIN', 18)}}的其他基金
A Phase II randomized controlled trial to evaluate the role of BB-12 in antibiotic-associated diarrhea and its effects on the gut microbiome
一项 II 期随机对照试验,旨在评估 BB-12 在抗生素相关性腹泻中的作用及其对肠道微生物组的影响
- 批准号:
10425501 - 财政年份:2021
- 资助金额:
$ 21.77万 - 项目类别:
Exploratory Pilot Studies to Demonstrate Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics
探索性试点研究展示预防抗生素相关腹泻的机制和益生菌的作用
- 批准号:
10480824 - 财政年份:2018
- 资助金额:
$ 21.77万 - 项目类别:
Exploratory Pilot Studies to Demonstrate Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics
探索性试点研究展示预防抗生素相关腹泻的机制和益生菌的作用
- 批准号:
10264947 - 财政年份:2018
- 资助金额:
$ 21.77万 - 项目类别:
Exploratory Pilot Studies to Demonstrate Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics
探索性试点研究展示预防抗生素相关腹泻的机制和益生菌的作用
- 批准号:
10222939 - 财政年份:2018
- 资助金额:
$ 21.77万 - 项目类别:
A Phase II randomized controlled trial to evaluate the role of BB-12 in antibiotic-associated diarrhea and its effects on the gut microbiome
一项 II 期随机对照试验,旨在评估 BB-12 在抗生素相关性腹泻中的作用及其对肠道微生物组的影响
- 批准号:
9296802 - 财政年份:2017
- 资助金额:
$ 21.77万 - 项目类别:
Yogurt beverages as a vehicle to deliver high dose probiotics
酸奶饮料作为提供高剂量益生菌的载体
- 批准号:
8491751 - 财政年份:2009
- 资助金额:
$ 21.77万 - 项目类别:
Yogurt beverages as a vehicle to deliver high dose probiotics
酸奶饮料作为提供高剂量益生菌的载体
- 批准号:
7314203 - 财政年份:2009
- 资助金额:
$ 21.77万 - 项目类别:
Yogurt beverages as a vehicle to deliver high dose probiotics
酸奶饮料作为提供高剂量益生菌的载体
- 批准号:
8440639 - 财政年份:2009
- 资助金额:
$ 21.77万 - 项目类别:
THE DRINK STUDY-DECREASING RATES OF ILLNESSES IN KIDS
饮料研究——降低儿童患病率
- 批准号:
7608332 - 财政年份:2006
- 资助金额:
$ 21.77万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 21.77万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 21.77万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 21.77万 - 项目类别:
Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 21.77万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 21.77万 - 项目类别:
Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 21.77万 - 项目类别:
Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
- 批准号:
DP240103257 - 财政年份:2024
- 资助金额:
$ 21.77万 - 项目类别:
Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
- 批准号:
DP240100408 - 财政年份:2024
- 资助金额:
$ 21.77万 - 项目类别:
Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
- 批准号:
DP240100111 - 财政年份:2024
- 资助金额:
$ 21.77万 - 项目类别:
Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
- 批准号:
502786 - 财政年份:2024
- 资助金额:
$ 21.77万 - 项目类别:
Directed Grant